Sarepta Therapeutics Inc
Change company Symbol lookup
Select an option...
SRPT Sarepta Therapeutics Inc
TSLA Tesla Motors Inc
NFX Newfield Exploration Co
BAC Bank of America Corp
IPDN Professional Diversity Network Inc
TTD Trade Desk Inc
CCL Carnival Corp
GRPN Groupon Inc
MDCA MDC Partners Inc
NCT Newcastle Investment Corp
Go

Health Care : Biotechnology | Small Cap BlendCompany profile

Sarepta Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of ribonucleic acid (RNA)-targeted therapeutics for the treatment of rare, infectious and other diseases. The Company operates in one segment: the development of pharmaceutical products on its own behalf or in collaboration with others. The Company, through its platform technologies, targets a range of diseases and disorders through RNA-targeted mechanisms of action. The Company is also developing therapeutics using its technology for the treatment of drug-resistant bacteria and infectious, rare and other human diseases. The Company's lead Duchenne Muscular Dystrophy (DMD) product candidate, Eteplirsen, is an antisense phosphorodiamidate morpholino oligomer (PMO) therapeutic in Phase III clinical development for the treatment of individuals with DMD having an error in the gene coding for dystrophin that is amenable to skipping exon 51.

Postmarket

Last Trade
Delayed
$59.00
-0.10 (-0.17%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$59.10
Day's Change
-0.56 (-0.94%)
Bid
--
Ask
--
B/A Size
--
Day's High
59.94
Day's Low
57.71
Volume
(Light)
Volume:
3,124,408
10-day average volume:
13,637,578
3,124,408
  • Prev Close
    59.66
  • Today's Open
    59.05
  • Day's Range
    57.71-59.94
  • Avg Vol (10-day)
    13.6M
  • Last (time)
    4:00p ET 09/27/16
  • Last (size)
    14
  • 52-Wk Range
    8.00 - 61.60
    LowHigh
  • (04/26/16 - 09/22/16)
    4.06%
  • 156.2%
  • Market Cap
    2.8B
  • Shares Outstanding
    47.9M
  • -5.35
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.1
  • 64.85
  • --

Latest News

September 22, 2016
6:00 pm ET
BusinessWire
September 21, 2016
4:16 pm ET
MarketWatch
4:03 pm ET
MarketWatch
4:03 pm ET
MarketWatch
4:02 pm ET
MarketWatch
4:00 pm ET
BusinessWire
10:00 am ET
BusinessWire
8:54 am ET
Globe Newswire
8:23 am ET
MarketWatch
7:39 am ET
Zacks
September 20, 2016
5:15 pm ET
BusinessWire
3:56 pm ET
MarketWatch
9:25 am ET
Zacks
9:13 am ET
Zacks
8:30 am ET
PR Newswire
8:29 am ET
MarketWatch
September 19, 2016
3:54 pm ET
MarketWatch
3:54 pm ET
MarketWatch
3:53 pm ET
MarketWatch
3:53 pm ET
MarketWatch
1:39 pm ET
BusinessWire
12:48 pm ET
MarketWatch
12:00 pm ET
MarketWatch
11:57 am ET
BusinessWire
10:43 am ET
MarketWatch
10:42 am ET
MarketWatch
10:14 am ET
MarketWatch
9:58 am ET
MarketWatch
9:54 am ET
MarketWatch
September 15, 2016
4:18 pm ET
Zacks
9:40 am ET
MarketWatch
9:10 am ET
Zacks
September 14, 2016
3:02 pm ET
MarketWatch
9:42 am ET
MarketWatch
August 26, 2016
8:57 am ET
Zacks
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2016 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by SunGard.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by , Computrade Systems, Inc.,, , and

Copyright © 2016. All rights reserved.